716-1063

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
716 (USA) · Dr. Ito
consented 2013-05-09

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild FATIGUE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-01 (study day 54.0); relationship: POSSIBLE

mild assessed

Mild HYPERHIDROSIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-09 (study day 366.0); relationship: PROBABLE

moderate assessed

Moderate LETHARGY — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-31 (study day 84.0); relationship: PROBABLE

mild assessed

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-04 (study day 57.0); relationship: PROBABLE

mild assessed

Mild PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-07-04 (study day 57.0); relationship: PROBABLE

moderate assessed

Moderate RESTLESSNESS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-28 (study day 81.0); relationship: PROBABLE

moderate assessed

Moderate RESTLESSNESS — outcome: RECOVERED/RESOLVED; onset 2013-07-28 (study day 81.0); relationship: PROBABLE

Data queries

No data queries.